EU Policy Priorities
Pfizer actively engages with the European Institutions and EU stakeholders to contribute to policy discussions and support initiatives that foster innovation, sustainability, and economic growth. By participating in constructive dialogue and sharing expertise, Pfizer supports policies that promote a competitive and sustainable business environment in the European Union.
Access to Medicines
Ensuring equitable access to innovative treatments for patients across Europe is a common responsibility, as birthplace should not define access to care.
Oncology
Fostering research and accelerating access to effective oncological treatments is essential to take us one step closer to beating cancer.
Industrial Policy
Putting a strong focus on competitiveness and industrial policy is a vital lesson Europe must learn from its recent challenges.
Sustainability
We integrate sustainable practices at every step, reducing our environmental impact while advancing healthcare.
Unmet Medical Needs
Defining and addressing unmet medical needs requires innovative solutions and collaboration to provide effective treatments where current options are lacking.
Supply Chains
Optimizing pharmaceutical supply chains is critical for ensuring timely access to medicines and bolstering healthcare resilience in the face of global challenges.
Digital Health
Digital technologies are revolutionizing healthcare, enabling personalized patient care and optimizing the distribution of medicines.